Related Experiment Video

Updated: Aug 8, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Natural human interferon alpha given orally has different effects on patients with distinct forms of chronic viral

J A Georgiades1, J Caban, T Zyrkowska-Bieda

  • 1Georgiades Foundation for Therapy of Chronic Disease, Stafford, TX 77477, USA.

Archivum Immunologiae Et Therapiae Experimentalis
|January 1, 1996
PubMed

Insights

For chronic viral hepatitis B (CVHB) patients, initial alanine amino transferase (ALAT) levels predict response to natural human interferon alpha (nHuIFN-alpha) lozenge therapy. Higher ALAT levels indicate a better outcome for this interferon treatment.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic viral hepatitis B (CVHB) poses a significant health challenge.
  • Treatment with natural human interferon alpha (nHuIFN-alpha) lozenges shows variable efficacy.
  • Identifying predictive markers for nHuIFN-alpha therapy is crucial for patient management.

Purpose of the Study:

  • To determine if baseline clinical, biochemical, or virological markers can predict patient response to nHuIFN-alpha lozenge therapy for CVHB.
  • To identify a reliable indicator for successful interferon treatment outcomes in hepatitis B patients.

Main Methods:

  • A cohort of 32 patients with persistent hepatitis B viremia (HBV) were treated with nHuIFN-alpha lozenges daily for 300 days.
  • Patients were assessed for clinical, liver function (including alanine amino transferase - ALAT), and virological markers.
  • Response to therapy was correlated with initial patient parameters.

Main Results:

  • Patients with an initial alanine amino transferase (ALAT) level above 100 IU demonstrated a high response rate (85.7%) to nHuIFN-alpha lozenge therapy.
  • Conversely, patients with an initial ALAT level below 100 IU showed a significantly lower response rate (9.0%).

Conclusions:

  • The baseline alanine amino transferase (ALAT) test is a valuable predictive indicator for the efficacy of natural human interferon alpha (nHuIFN-alpha) lozenge therapy in patients with chronic viral hepatitis B.
  • This finding can aid clinicians in selecting appropriate patients for interferon treatment and managing expectations regarding treatment outcomes.

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...